Docoh
Loading...

MRVI Maravai LifeSciences

Employees

Data from SEC filings
Employee count

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM


On May 19, 2021, the Company held its 2021 Annual Meeting of Shareholders (the “Annual Meeting”). At the close of business on March 22, 2021, the record date of the Annual Meeting, the Company had an aggregate of 257,620,644 shares of common stock issued and outstanding, consisting of 96,646,515 shares of Class A Common Stock and 160,974,129 shares of Class B Common Stock (together, the “Common Stock”). The holders of a total of 251,208,233 shares of Common Stock were present at the Annual Meeting, either in person or by proxy, which constituted a quorum for the purpose of conducting business at the Annual Meeting.

Set forth below are the final voting results for each proposal submitted to a vote of the shareholders at the Annual Meeting.

Proposal No. 1: Election of directors.

The Company’s shareholders elected the following nominees for director to serve as Class I directors for a term expiring in 2024 or until their successors shall have been elected and qualified.

NomineeVotes ForVotes WithheldBroker Non-Votes
Benjamin Daverman225,457,61323,266,3742,484,246
Susannah Gray248,443,065280,9222,484,246
Carl Hull245,987,0702,736,9172,484,246
Constantine Mihas225,441,24023,282,7472,484,246


Proposal No. 2: Proposal to approve, by an advisory vote, the retention of the classified structure of the Board of Directors.

The retention of the classified structure of the Board of Directors was approved on an advisory basis.

Votes ForVotes AgainstAbstentionsBroker Non-Votes
196,349,70752,361,53612,7442,484,246


Proposal No. 3: Proposal to approve, by an advisory vote, the retention of the supermajority voting standards in the Company’s Amended and Restated Certificate of Incorporation and the Company’s Amended and Restated Bylaws.

The retention of the supermajority voting standards in the Company’s Amended and Restated Certificate of Incorporation and the Company’s Amended and Restated Bylaws was approved on an advisory basis.

Votes ForVotes AgainstAbstentionsBroker Non-Votes
196,328,41352,388,6336,9412,484,246




Proposal No. 4: Proposal to ratify of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021.

The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021 was ratified.

Votes ForVotes AgainstAbstentionsBroker Non-Votes
251,161,28642,2994,6480